JPMorgan Chase & Co. Begins Coverage on PACS Group (NYSE:PACS)

JPMorgan Chase & Co. assumed coverage on shares of PACS Group (NYSE:PACS) in a research report report published on Monday, MarketBeat Ratings reports. The firm issued an overweight rating and a $27.00 price target on the stock.

Other equities research analysts have also issued research reports about the stock. Royal Bank of Canada started coverage on shares of PACS Group in a research note on Monday. They issued an outperform rating and a $30.00 price target on the stock. Oppenheimer started coverage on PACS Group in a research note on Monday. They set an outperform rating and a $31.00 target price on the stock. Truist Financial assumed coverage on PACS Group in a research note on Monday. They issued a buy rating and a $32.00 price target for the company. Finally, Citigroup started coverage on shares of PACS Group in a research note on Monday. They set a buy rating and a $32.00 price objective on the stock. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of Buy and an average price target of $30.50.

PACS Group Stock Down 1.3 %

PACS stock opened at $24.67 on Monday. PACS Group has a fifty-two week low of $22.61 and a fifty-two week high of $25.72.

Insider Activity

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the firm’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the completion of the transaction, the chief executive officer now owns 62,754,551 shares in the company, valued at approximately $1,317,845,571. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.